| Product Code: ETC7539076 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India candidiasis therapeutics market import shipments experienced a notable decline with a CAGR of -17.2% from 2020 to 2024. However, there was a remarkable surge in growth between 2023 and 2024, showcasing a momentum shift towards rapid expansion. Despite the overall decline, the market displayed signs of resurgence and potential recovery in the given period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Candidiasis Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Candidiasis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Candidiasis Therapeutics Market - Industry Life Cycle |
3.4 India Candidiasis Therapeutics Market - Porter's Five Forces |
3.5 India Candidiasis Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Candidiasis Therapeutics Market Revenues & Volume Share, By Symptom Type, 2021 & 2031F |
3.7 India Candidiasis Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 India Candidiasis Therapeutics Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.9 India Candidiasis Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 India Candidiasis Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Candidiasis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of candidiasis infections in India |
4.2.2 Growing awareness about candidiasis and its treatment options |
4.2.3 Advancements in healthcare infrastructure and facilities in India |
4.3 Market Restraints |
4.3.1 Lack of proper diagnosis and underreporting of candidiasis cases |
4.3.2 Limited availability of effective treatment options |
4.3.3 High cost associated with candidiasis therapeutics |
5 India Candidiasis Therapeutics Market Trends |
6 India Candidiasis Therapeutics Market, By Types |
6.1 India Candidiasis Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Candidiasis Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Candidiasis Therapeutics Market Revenues & Volume, By Oropharyngeal Candidiasis, 2021- 2031F |
6.1.4 India Candidiasis Therapeutics Market Revenues & Volume, By Genital Candidiasis, 2021- 2031F |
6.1.5 India Candidiasis Therapeutics Market Revenues & Volume, By Invasive Candidasis, 2021- 2031F |
6.2 India Candidiasis Therapeutics Market, By Symptom Type |
6.2.1 Overview and Analysis |
6.2.2 India Candidiasis Therapeutics Market Revenues & Volume, By Oral Thrush, 2021- 2031F |
6.2.3 India Candidiasis Therapeutics Market Revenues & Volume, By Fatigue, 2021- 2031F |
6.2.4 India Candidiasis Therapeutics Market Revenues & Volume, By Urinary Tract Infection (UTI), 2021- 2031F |
6.3 India Candidiasis Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 India Candidiasis Therapeutics Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 India Candidiasis Therapeutics Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4 India Candidiasis Therapeutics Market, By Mode of Administration |
6.4.1 Overview and Analysis |
6.4.2 India Candidiasis Therapeutics Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.3 India Candidiasis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.5 India Candidiasis Therapeutics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Candidiasis Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 India Candidiasis Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 India Candidiasis Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 India Candidiasis Therapeutics Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 India Candidiasis Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 India Candidiasis Therapeutics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 India Candidiasis Therapeutics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 India Candidiasis Therapeutics Market Import-Export Trade Statistics |
7.1 India Candidiasis Therapeutics Market Export to Major Countries |
7.2 India Candidiasis Therapeutics Market Imports from Major Countries |
8 India Candidiasis Therapeutics Market Key Performance Indicators |
8.1 Number of diagnosed candidiasis cases in India |
8.2 Adoption rate of new treatment options for candidiasis |
8.3 Investment in research and development for candidiasis therapeutics |
9 India Candidiasis Therapeutics Market - Opportunity Assessment |
9.1 India Candidiasis Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Candidiasis Therapeutics Market Opportunity Assessment, By Symptom Type, 2021 & 2031F |
9.3 India Candidiasis Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 India Candidiasis Therapeutics Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.5 India Candidiasis Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 India Candidiasis Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Candidiasis Therapeutics Market - Competitive Landscape |
10.1 India Candidiasis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Candidiasis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here